"RNA, Neoplasm" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
RNA present in neoplastic tissue.
| Descriptor ID |
D012334
|
| MeSH Number(s) |
D13.444.735.615
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "RNA, Neoplasm".
Below are MeSH descriptors whose meaning is more specific than "RNA, Neoplasm".
This graph shows the total number of publications written about "RNA, Neoplasm" by people in this website by year, and whether "RNA, Neoplasm" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 3 | 4 |
| 1997 | 1 | 1 | 2 |
| 1998 | 0 | 2 | 2 |
| 2000 | 0 | 3 | 3 |
| 2001 | 1 | 1 | 2 |
| 2002 | 0 | 2 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 3 | 4 |
| 2005 | 1 | 2 | 3 |
| 2006 | 1 | 4 | 5 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 4 | 4 |
| 2009 | 0 | 3 | 3 |
| 2010 | 1 | 2 | 3 |
| 2012 | 1 | 1 | 2 |
| 2013 | 3 | 2 | 5 |
| 2014 | 0 | 3 | 3 |
| 2015 | 2 | 4 | 6 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 2 | 1 | 3 |
| 2019 | 1 | 1 | 2 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 1 | 2 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "RNA, Neoplasm" by people in Profiles.
-
Gene-gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer. Eur J Med Res. 2022 Jan 31; 27(1):14.
-
RNA-driven JAZF1-SUZ12 gene fusion in human endometrial stromal cells. PLoS Genet. 2021 12; 17(12):e1009985.
-
YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner. Blood. 2021 07 08; 138(1):71-85.
-
Addiction to Golgi-resident PI4P synthesis in chromosome 1q21.3-amplified lung adenocarcinoma cells. Proc Natl Acad Sci U S A. 2021 06 22; 118(25).
-
Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression. Cancer Res. 2020 09 15; 80(18):3810-3819.
-
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas. Cell Rep. 2019 07 30; 28(5):1370-1384.e5.
-
Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma. Graefes Arch Clin Exp Ophthalmol. 2019 Jul; 257(7):1541-1545.
-
Vimentin overexpression as a novel poor prognostic biomarker in eyelid sebaceous gland carcinoma. Br J Ophthalmol. 2020 06; 104(6):879-884.
-
MicroRNAs as prognostic markers in prostate cancer. Prostate. 2019 02; 79(3):265-271.
-
The number of titrated microRNA species dictates ceRNA regulation. Nucleic Acids Res. 2018 05 18; 46(9):4354-4369.